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Changes in histone methylation status regulate
chromatin structure and DNA-dependent pro-
cesses such as transcription. Recent studies
indicate that, analogous to other histonemodifi-
cations, histone methylation is reversible. Reti-
noblastoma binding protein 2 (RBP2), a nuclear
protein implicated in the regulation of transcrip-
tion and differentiation by the retinoblastoma
tumor suppressor protein, contains a JmjC do-
main recently defined as a histone demethylase
signature motif. Here we report that RBP2 is
a demethylase that specifically catalyzes deme-
thylation on H3K4, whose methylation is nor-
mally associated with transcriptionally active
genes. RBP2/ mouse cells displayed en-
hanced transcription of certain cytokine genes,
which, in the case of SDF1, was associated
with increased H3K4 trimethylation. Further-
more, RBP2 specifically demethylated H3K4
in biochemical and cell-based assays. These
studies provide mechanistic insights into tran-
scriptional regulation by RBP2 and provide the
first example of a mammalian enzyme capable
of erasing trimethylated H3K4.
INTRODUCTION
Histones are subject to a variety of posttranslational mod-
ifications that affect chromatin structure and therefore in-
fluence processes such as transcription and DNA repair.
These modifications include acetylation, methylation,
phosphorylation, sumoylation, and ubiquitylation (re-
viewed in Shilatifard, 2006).Recent studies have highlighted the importance of his-
tone methylation on specific lysine residues with respect
to gene regulation. Three families of enzymes are capable
of mediating histone-lysyl methylation: the PRMT1 family,
the SET-domain-containing protein family, and the non-
SET-domain proteins DOT1 and DOT1L (reviewed in
Martin and Zhang, 2005). Specific histone-lysyl residues
can become mono- (me1), di- (me2), or trimethylated
(me3). Whether methylation leads to transcriptional activa-
tion or repression is influenced by a variety of factors, in-
cluding the histone (for example, H3 versus H4), the lysine
acceptor (for example, H3K4 versus H3K9), the histone
location (for example, whether bound to a coding versus
noncoding region of a gene), and other contextual influ-
ences. In general, methylation on H3K9, H3K27, or
H4K20 is linked to formation of tightly packed chromatin
(heterochromatin) and gene silencing while methylation
on H3K4, H3K36, and H3K79 is associated with actively
transcribed regions (euchromatin) (Martin and Zhang,
2005). The effect of histone methylation on chromatin
structure is probably not direct but, rather, through the re-
cruitment of proteins that recognize and bind to methyl-
ated lysine. To date, four protein subdomains that are ca-
pable of binding to methylated lysine have been identified:
the chromodomain (Bannister et al., 2001; Fischle et al.,
2003; Lachner et al., 2001; Min et al., 2003; Pray-Grant
et al., 2005), the tudor domain (Huang et al., 2006; Huyen
et al., 2004; Sanders et al., 2004), the WD40 repeat
(Wysocka et al., 2005), and the plant homeodomain
(PHD) (Li et al., 2006; Pena et al., 2006; Shi et al., 2006;
Wysocka et al., 2006).
Histone-lysyl methylation, like histone acetylation, is
reversible. The first lysyl demethylase to be identified was
lysine-specific demethylase 1 (LSD1), which demethylates
H3K4 or H3K9 in a reaction that utilizes flavin as a cofactor
and which is limited to mono- or dimethylated substrates
(Shi et al., 2004). In 2005 Trewick and coworkers predicted
the existence of a second class of histone demethylases
that contain a JmjC domain (Trewick et al., 2005), whichCell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc. 889
is a motif present in many proteins that are known, or sus-
pected, to play roles in transcription. They noted that the
JmjC domain of the yeast protein Epe1 could be modeled
onto the JmjC domain of the FIH1 protein hydroxylase,
which utilizes iron and 2-oxoglutarate as cofactors to
hydroxylate HIF. Moreover, FIH1 residues necessary for
binding to iron and 2-oxoglutarate appeared to be con-
served in at least a subset of JmjC domains. They specu-
lated that some JmjC proteins might hydroxylate methyl-
ated lysine residues, which would then spontaneously
undergo conversion to unmethylated lysine with release
of formaldehyde. This hypothesis was informed by the ear-
lier observation that the 2-oxoglutarate and iron-
dependent hydroxylase AlkB demethylates damaged
DNA in an analogous reaction (Falnes et al., 2002; Trewick
et al., 2002).
Zhang and coworkers independently came to these
same conjectures and successfully isolated the JmjC do-
main protein JHDM1 upon purifying a histone H3K36 de-
methylase activity from cells, using formaldehyde release
as their readout (Tsukada et al., 2006). Since that time,
several other JmjC-domain-containing proteins have
been shown to possess histone demethylase activity to-
ward specific histone methylation marks (Cloos et al.,
2006; Fodor et al., 2006; Klose et al., 2006b; Whetstine
et al., 2006; Yamane et al., 2006). Thirty JmjC-domain-
containing proteins have been identified in humans, which
can be phylogenetically divided into seven subfamilies
(JHDM1, JHDM2, PHF2/PHF8, JARID, JHDM3/JMJD2,
UTX/UTY, and JmjC-domain-only family) (Klose et al.,
2006a). So far only members of the JHDM1, JHDM2,
and JHDM3/JMJD2 families have been shown to possess
histone demethylase activity (Klose et al., 2006a). It is un-
likely that all of the human JmjC-domain proteins are de-
methylases since some have nonconservative substitu-
tions at residues that are predicted to be important for
coordinating iron and 2-oxoglutarate.
RBP2 is a nuclear phosphoprotein that was initially
identified as a potential pRB binding protein (Defeo-
Jones et al., 1991). Native chromatin-associated pRB-
RBP2 complexes are detected in response to signals
that affect cell-cycle exit and induction of differentiation
(Benevolenskaya et al., 2005). RBP2 is encoded by one
of the four paralogous JARID-family genes in humans
(Kortschak et al., 2000; Wilsker et al., 2005) and, in addi-
tion to a JmjC domain, contains other domains that are
frequently found in transcriptional regulators, including
a JmjN domain, a Bright/Arid domain, a C5H2C zinc
finger, and several PHD domains. The Drosophila RBP2
ortholog, Lid, was originally identified in a screen for
novel Trithorax member genes (Gildea et al., 2000), which
also implies a potential role for RBP2 in transcriptional
regulation. It appears that free RBP2 can repress certain
genes involved in differentiation and that binding to pRB
converts RBP2 from a transcriptional repressor to a tran-
scriptional activator (Benevolenskaya et al., 2005). How,
mechanistically, RBP2 regulates transcription is not
known.890 Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc.RESULTS
RBP2 Is a Histone Demethylase
The JmjC domain of JARID1 proteins share extensive sim-
ilarity to the JmjC domain of the JHDM3 demethylases,
which target removal of H3K9/36 methylation and can re-
move the trimethyl modification state (Figure 1A). Conser-
vation of residues within the predicted cofactor binding
sites of the RBP2 JmjC domain and the apparent role of
RBP2 as a transcriptional regulator led us to ask if RBP2
possessed histone demethylase activity and, if so,
whether this activity might be directed toward a histone
methylation mark that was not recognized by the previ-
ously characterized JmjC-family members.
In pilot experiments we discovered that partially purified
RBP2 from mammalian cell extracts could specifically de-
methylate trimethylated H3K4, suggesting that RBP2, or
perhaps an associated protein, was responsible for this
activity (data not shown).
Currently, LSD1 is the only characterized H3K4 deme-
thylase, but its catalytic requirement for a protonated
nitrogen on the lysine-amine group limits its enzymatic ac-
tivity to H3K4me1/me2 modified substrates (Lee et al.,
2005; Metzger et al., 2005; Shi et al., 2004, 2005). The in-
ability of LSD1 to reverse H3K4me3 left open the possibil-
ity that this modification state is refractory to enzymatic
demethylation. In contrast to LSD1, the JmjC-domain-
containing histone demethylases exploit a direct hydroxyl-
ation reaction to remove histone methylation, suggesting
that RBP2 might catalyze the removal of H3K4me3.
To verify that RBP2 is an H3K4 demethylase and to
examine the modification-state specificity of RBP2,
Flag-tagged RBP2 was expressed in SF9 cells using a ba-
culovirus expression system and affinity purified to homo-
geneity. Purified Flag-RBP2 resolved as a single band fol-
lowing SDS-PAGE and Coomassie blue or silver staining
(Figure 1B). Recombinant RBP2 was then incubated with
radioactively labeled histone substrates and demethylase
activity analyzed by formaldehyde release. Recombinant
RBP2 only caused release of radioactive formaldehyde
when H3K4-methylated substrates were used indicating
that recombinant RBP2 is an H3K4 demethylase
(Figure 1C). To probe the modification-state specificity
of RBP2, recombinant RBP2 was incubated in a histone
demethylase assay with modified histone H3 peptide sub-
strates corresponding to the H3K4 me3, me2, and me1
modification states (Figures 1D–1F). RBP2 displayed ro-
bust H3K4 demethylase activity against H3K4me3 and
me2 (Figures 1D and 1E), resulting in 80%–90% demethy-
lation of the modified substrate (Figures 1G and 1H), but
failed to catalyze removal of the me1 modification state
(Figure 1F). Although RBP2 fails to initiate demethylation
of H3K4me1 in vitro (Figure 1F), it is capable of proces-
sively demethylating the H3K4me3 and me2 modifications
to the unmodified state (Figures 1D and 1E). This enzy-
matic property of RBP2 is similar to the other trimethyl de-
methylase, JHDM3A, which also catalyzes processive re-
moval of all three modification states but fails to initiate
Figure 1. RBP2 Is an H3K4 Demethylase
(A) The JmjC domain of the JARID1 subfamily is highly similar to the JmjC domain of JHDM3 demethylase enzymes. The predicted Fe(II) (red shading)
and aKG binding (blue shading) residues are conserved in RBP2 and other JARID1 members.
(B) Recombinant Flag-RBP2 was expressed in insect cells, affinity purified by Flag chromatography, and analyzed by SDS-PAGE followed by
Coomassie blue or silver staining.
(C) Recombinant Flag-RBP2 was incubated with labeled histone substrates and demethylase activity monitored by formaldehyde release. RBP2
demethylates H3K4-methylated substrate.
(D–F) Mass-spectrometry analysis of RBP2 activity toward H3K4me3 (D), H3K4me2 (E), and H3K4me1 (F) peptides.
(G–H) Quantification of demethylation levels observed for RBP2 on H3K4me3 (G) and H3K4me2 (H) substrates.Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc. 891
demethylation on the me1 modification state in vitro
(R.J.K. and Y.Z., unpublished observations). Together,
these observations indicate that the H3K4me3 modifica-
tion state is enzymatically reversible and suggests that
histone demethylation contributes to transcriptional regu-
lation by RBP2.
RBP2 Demethylates H3K4 In Vivo
To ask whether RBP2 functions as an active H3K4 deme-
thylase in vivo, a Flag-tagged RBP2 expression plasmid
was transfected into NIH3T3 cells, and its effect on
H3K4 methylation was analyzed by indirect immunofluo-
rescence using H3K4 methylation specific antibodies
(Figure 2). Cells overexpressing RBP2 showed a uniform
reduction of H3K4me1, me2, and me3 modifications (Fig-
ures 2A–2C, top panels). Removal of H3K4 methylation
was dependent on the demethylase activity of RBP2 as
a point mutation in the predicted JmjC-domain iron bind-
ing site (H483A) abrogated the H3K4 demethylation (Fig-
ures 2A–2C, bottom panels). Surprisingly, given the inabil-
ity of recombinant RBP2 to demethylate the H3K4me1
in vitro, RBP2 efficiently catalyzed removal of the
H3K4me1 in vivo. This observation suggests that capacity
of the RBP2 to catalyze H3K4me1-specific demethylation
is regulated by additional factors or modifications specific
to mammalian RBP2 in vivo. Collectively, these data indi-
cate that RBP2 is able to demethylate all the H3K4 meth-
ylation states in vivo and demonstrate the H3K4me3 is
a readily reversible histone modification.
Generation of RBP2/ Mice
Cell-culture experiments suggest that RBP2 plays a role in
differentiation control by the retinoblastoma tumor sup-
pressor protein (pRB). To begin to study the functions of
RBP2 in vivo, and its genetic interactions with RB1, we
set out to make RBP2/ mice. Toward this end we
made a gene-targeting vector in which RBP2 exons 5
and 6 were flanked by LoxP sites (Figure 3A). For positive
and negative selection purposes this vector also con-
tained a Neomycin resistance cassette, which was
flanked by Frt sites, and a Diptheria toxin cassette, re-
spectively. The elimination of exons 5 and 6 removes se-
quences that encode a portion of the RBP2 Bright/Arid
domain and changes the RBP2 reading frame 30 of the
exon 4-exon 7 junction, leading to loss of the JmjC, zinc
finger, and PHD domains.
The gene-targeting vector was introduced into 129/
SvEv embryonic stem cells by electroporation followed
by selection with G418. Cells that had undergone suc-
cessful homologous recombination, as determined by
PCR and Southern blot analysis, were injected into
C57BL/6 blastocysts. High-percentage chimeras were
backcrossed to C57BL/6 mice, which were sequentially
bred to CAGG-Flpe mice, to remove the Neomycin resis-
tance cassette, and to EIIa-Cre mice to generate the null
RBP2 allele. Once germline transmission of the null
RBP2 allele was confirmed RBP2+/ males were mated
with RBP2+/ females. Viable RBP2/ offspring were892 Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc.produced at the expected Mendelian frequency, and their
survival does not appear to be compromised during the
first nine months of life, the observation period available
to date (Figures 3B and 3C, Table S1, and data not shown).
As expected full-length RBP2 mRNA and protein were un-
detectable in RBP2/ MEFs (Figures 3D and 3E). By
real-time RT-PCR analysis we detected a weak signal us-
ing mRNA isolated fromRBP2/MEFs and primers spe-
cific for RBP2 exons 1–3, presumably because the altered
RBP2 mRNA is highly unstable (Figure 3D).
RBP2/ mice exhibited characteristic behavioral
abnormalities when held upside down by the tail but
Figure 2. RBP2 Demethylates H3K4 In Vivo
(A–C) Flag-RBP2 or Flag-RBP2 containing a mutation in the proposed
iron binding site (H483A) was expressed in NIH3T3 cells. The levels of
H3K4 methylation were analyzed using modification-specific anti-
bodies against (A) H3K4me1, (B) H3K4me2, and (C) H3K4me3 by indi-
rect immunofluorescence (middle panels). Cells expressing wild-type
and mutant RBP2 were identified by Flag immunofluoresence (left
panels), and nuclei were identified by DAPI staining (right panels). Ar-
rowheads in the middle and right panels indicate transfected cells.
RBP2 demethylates all three H3K4 methylation states in vivo.
Figure 3. Generation of RBP2/ Mice
(A) Schematic of RBP2 genomic locus and re-
combinant alleles. Exons are depicted by the
open boxes with exon number inside. Frt and
LoxP sites are indicated by filled rectangles
and triangles, respectively.
(B) Multiplex PCR using primers indicated in (A)
(arrows) and genomic DNA extracted from
mouse tails.
(C) Southern blot analysis of genomic DNA, iso-
lated from mouse tails, after digestion with SphI
and hybridization with 50 probe shown in (A).
(D) Quantitative, real-time RT-PCR analysis of
total RNA from RBP2+/+ (WT) and RBP2/
(KO) MEFs using primers specific for exons
1–3 (top panel) or exons 5 and 6 (bottom panel).
Data were normalized to GAPDH mRNA abun-
dance and are represented as mean ± standard
deviation (SD).
(E) Western blot analysis of MEFs with the indi-
cated genotypes.otherwise appear to be grossly normal (data not shown).
Analysis of the peripheral blood of 6-week- or 23-week-
old RBP2/ animals showed a relative (44% versus
58% for wild-type versus RBP2/ mice, respectively)
and absolute neutrophilia compared to littermate con-
trols. This prompted a detailed analysis of the hematopoi-
etic stem cell (HSC) and myeloid progenitor compart-
ments by high-speed multiparameter flow cytometry.
There was not a significant difference in the number of
LSK (Lin Sca-1+ c-kit+) cells that contain both long-
term and short-term HSC, nor were there statistically sig-
nificant quantitative changes in the myeloid progenitor
compartment that is comprised of common myeloid
progenitors (CMP), granulocyte-monocyte progenitors
(GMP), and megakaryocyte-erythrocyte progenitors
(MEP). However, analysis of the HSC and myeloid progen-
itor compartments showed a statistically significant de-
crease in the rate of apoptosis in both hematopoietic com-
partments, as assessed by staining with the 7-AAD
viability dye and Annexin V (Figures 4A and 4B; 2-fold
for both HSC and myeloid progenitors; p = 0.005 and
p = 0.04, respectively). Cell-cycle analysis of the HSC
and myeloid progenitors using Hoechst 33342 and Pyro-nin Y staining showed an increase in the percentage of
G0/1 HSC and myeloid progenitor cells in G1 (Figures
4C and 4D), indicating increased exit out of quiescence
and a trend toward an increased proportion of myeloid
progenitor cells entering the S/G2/M phase of the cell
cycle (33% versus 40% in wild-type and RBP2/
mice, respectively; p < 0.07). Thus, there were quantitative
differences in the HSC and myeloid progenitors of RBP2-
deficient mice that were consistent with enhanced survival
and increased cycling in these compartments. A more
complete phenotypic description of the RBP2/ mice
will appear at a later date.
Identification of RBP2-Responsive Genes
To begin to understand the molecular basis for these ab-
normalities and RBP2’s role in transcriptional regulation,
we performed mRNA profiling using DNA microarrays on
proliferating RBP2+/+ and RBP2/ MEFs grown under
standard culture conditions (Tables 1 and S2). In replicate
experiments the mRNAs encoding chemokine CXCL12/
SDF1, c-Kit ligand, chemokine CXCL5, and chemokine
CXCL1/Gro1 were increased in RBP2/ cells relative
to wild-type controls. At the same time, loss of RBP2 ledCell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc. 893
to decreased levels of a handful of mRNAs, many of which
encode proteins of unknown function.
We initially focused on SDF1 because it was, quantita-
tively, the most RBP2-responsive mRNA amongst the cy-
tokines mentioned above and because transgenic expres-
sion of SDF1 in the mouse under the control of the Rous
sarcoma virus promoter is sufficient to cause some
of the hematological abnormalities we observed in
RBP2/ mice, including increased cell cycling and en-
hanced survival of myeloid progenitor cells (Broxmeyer
et al., 2003a; Broxmeyer et al., 2003b). Increased expres-
sion of SDF1 mRNA and protein by RBP2/ relative to
RBP2+/+ cells was confirmed by real-time RT-PCR and
ELISA, respectively (Figures S1A and S1B). Moreover,
RBP2 bound specifically to the SDF1 promoter as deter-
mined by chromatin immunoprecipitation (ChIP) (Figures
S1C; see also Figures 5A and 5B). Recovery of the SDF1
promoter with the anti-RBP2 sera in these assays was,
as expected, substantially reduced when these assays
were performed with RBP2/ MEFs (data not shown;
Figure 4. RBP2 Knockout Mice Display Decreased Apoptosis
and Increased Entry into G1 Phase of Cell Cycle in HSC and
Myeloid Progenitor Compartments
(A and B) Bone-marrow cells isolated from 23-week-oldRBP2 +/+ (WT)
(n = 3) and RBP2/ (KO) (n = 6) animals were stained for hematopoi-
etic stem cell and progenitor markers, and apoptosis was assessed
using 7-AAD and Annexin-V staining. RBP2-deficient HSC (LSK =
Lin Sca-1+ c-kit+) and myeloid progenitors (‘‘Myel prog’’) show de-
creased rates of apoptosis when compared to their wild-type litter-
mates. Data are represented as mean ± standard error of the mean
(SEM).
(C and D) Bone-marrow cells isolated from 23-week-old RBP2 +/+
(WT) (n = 3) and RBP2/ (KO) (n = 4) animals were stained for hema-
topoietic stem cell and progenitor markers, and the cell-cycle status
was determined using Hoechst 33342 and Pyronin Y staining. RBP2-
deficient HSC (LSK) and myeloid progenitors (‘‘Myel prog’’) exhibit
an increased entry into G1 phase (defined as % of G0-G1 cells in
G1) of cell cycle when compared to their wild-type littermates. Data
are represented as mean ± SEM.894 Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc.see also Figure 5B). Therefore SDF1 appears to be a direct
target of RBP2 mediated repression. SDF1 expression
was reproducibly increased in the muscle from RBP2/
mice relative to wild-type mice (Figure S1D). In contrast,
SDF1 expression was not detectably increased in
RBP2/ brain, liver, bone marrow, and spleen (data
not shown), suggesting that regulation of SDF1 by RBP2
might be cell-type specific. Clearly additional studies will
be needed to determine the relative contribution of SDF1
to the phenotypic abnormalities noted above in RBP2/
mice.
The availability of RBP2/ mouse cells allowed us to
also ask if RBP2, in addition to being sufficient (Figure 2),
is also necessary for the demethylation of H3K4 in vivo.
Immunoblot analysis using antibodies that recognize spe-
cific histone methylation marks, including an antibody
specific for trimethylated H3K4, did not reveal any signifi-
cant differences between wild-type and RBP2/ MEFs
(Figure S2A). Similar results were observed when RBP2
was acutely inactivated in MEFs homozygous for the
floxed RBP2 allele (Figures 3A and S2B), suggesting that
developmental plasticity does not account for the similar-
ity between wild-type andRBP2/MEFs with respect to
the total pool of methylated H3K4. However, decreased
trimethylated H3K4, with a commensurate increased di-
methylated H3K4, was detected on the SDF1 promoter
by ChIP in RBP2+/+ cells relative to RBP2/ cells (Fig-
ures 5 and S3). This change was specific because H3K4
trimethylation was not altered in SDF1 genomic fragments
distant from the RBP2 binding site (Figure 5 and data not
shown).
Finally, RBP2/ cells were infected with retroviruses
encoding wild-type RBP2 or RBP2-H483A. As expected,
wild-type, but not mutant, RBP2 demethylated the SDF1
promoter as determined by ChIP assay (Figure 6). Collec-
tively, these results suggest that RBP2 is recruited to spe-
cific regions of the genome and is capable of acting as an
H3K4 demethylase in vitro and in vivo.
DISCUSSION
As is true for many transcription factors, RBP2 can act as
a transcriptional activator or a transcriptional repressor in
a context-dependent manner (Benevolenskaya et al.,
2005; Chan and Hong, 2001). Demethylation of H3K4
likely contributes to RBP2’s ability to repress transcription
since trimethylated H3K4 is often associated with tran-
scriptionally active genes. RBP2 also physically interacts
with a complex that contains histone-deacetylase activity
(Q.Y. and W.G.K., unpublished data), suggesting that tran-
scriptional repression by RBP2 might also involve addi-
tional mechanisms. In support of this, the RBP2-H483A
mutant significantly repressed SDF1 expression when re-
introduced intoRBP2/mouse embryo fibroblasts (data
not shown).
Furthermore, in light of the recent findings that histone
demethylase activity of LSD1 is regulated by its associ-
ated factors (Lee et al., 2005; Shi et al., 2005; Yang
Table 1. List of Genes Up- or Downregulated by 2-Fold or More in RBP2 / MEFs
Gene Name Gene ID
Expression Level KO/WT
Experiment 1 Experiment 2 Average
Cxcl12/Sdf1 20315 6.1 10.0 8.1
Cxcl12/Sdf1 20315 5.8 7.1 6.4
Cxcl5 20311 5.1 2.9 4
Foxp2 114142 3.6 4.3 3.9
Mtm1 17772 5.1 2.6 3.8
Efemp1 216616 5.0 2.0 3.5
Cxcl1/Gro1 14825 4.3 2.1 3.2
H60 15101 2.5 3.8 3.1
Ifi204 15951/672547 3.9 2.1 3
Cdkn1b/p27 12576 3.3 2.6 2.9
Nt5e 23959 3.4 2.3 2.9
Mgp 17313 2.0 2.9 2.5
BC049816 232313 3.1 1.7 2.4
Dcn 13179 3.1 1.7 2.4
Kitl/SCF 17311 2.7 1.9 2.3
Aebp2 11569 2.3 2.2 2.3
2610044O15Rik 72139 2.1 2.1 2.1
Arhgdib 11857 2.4 1.7 2.1
Ppm2c 381511 2.3 1.7 2
Foxp1 108655 1.8 2.2 2
Prdx2 21672 2.2 2.5 2.4
Foxp1 108655 1.9 3.2 2.6
Rbp2/Jarid1a 214899 3.4 3.6 3.5
Sorbs1 20411 3.7 4.7 4.2
Sema4a 20351 7.5 4.3 5.9
Kcnd3 56543 17.4 2.5 10et al., 2006), RBP2’s histone-demethylase activity might
also be modulated by associated protein factors in vivo.
Such factors might, based on our work, influence whether
RBP2 can recognize, and act upon, monomethylated
H3K4 for example. Studies are currently underway to
explore this possibility.
RBP2 contains both a canonical pRB binding motif, first
identified in viral oncoproteins such as SV40 T, adenovirus
E1A, and HPV E7, and a noncanonical pRB binding motif
(Benevolenskaya et al., 2005; Defeo-Jones et al., 1991;
Fattaey et al., 1993; Kim et al., 1994). pRB’s ability to serve
as a transcriptional coactivator, as well as its ability to pro-
mote differentiation, when reintroduced intoRB1/ cells
in vitro, are both tightly correlated with pRB’s ability to
bind to RBP2 (Benevolenskaya et al., 2005). Moreover,
these pRB attributes can be phenocopied by downregu-
lating RBP2 in RB1/ cells using siRNA (Benevolen-
skaya et al., 2005), suggesting that pRB and RBP2 antag-onize one another and that pRB neutralizes RBP2 as
a transcriptional repressor. On the other hand, RBP2
and pRB cooperate with one another to activate genes
such as the bromodomain genes Brd2 and Brd8 (Benevo-
lenskaya et al., 2005), suggesting that the functional inter-
action of pRB and RBP2 is actually more complex. It will
be of interest to determine how and if binding to pRB alters
RBP2 demethylase activity and whether pRB utilizes
RBP2’s demethylase activity in certain contexts to enforce
changes in gene expression.
Based on their primary sequence similarity to RBP2, it is
likely that all four JARID1 members act as H3K4 demethy-
lases. Indeed, H3K4 demethylase activity has been ob-
served for JARID1D (R. Shiekhattar, personal communi-
cation). JARID1B (PLU1), like RBP2, has been reported
to act as a transcriptional repressor (Tan et al., 2003) . Pre-
liminary results indicate it also possesses H3K4 demethy-
lase activity (K. Y., R.J.K, and Y. Z., unpublished results).Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc. 895
Figure 5. RBP2 Binds to and Demethy-
lates H3K4me3 at the SDF1 Promoter
(A) Schematic of the mouse SDF1 genomic
locus. The regions p1–p5 were analyzed by
ChIP experiments.
(B–D) Relative abundance of RBP2 (B),
H3K4me3 (C), and H3 (D) on the SDF1 genomic
regions, as determined by quantitative, real-
time PCR analysis following ChIP of
RBP2 +/+ (WT) and RBP2/ (KO) MEFs with
the corresponding antibodies. Data are repre-
sented as mean ± SEM.Interestingly, JARID1C (SMCX) and JARID1D (SMCY)
map to the X and Y chromosome, respectively, raising
the possibility that they play a role in establishing gen-
der-specific gene-expression patterns. In fact, mutations
in the JARID1C gene are associated with X-linked mental
retardation (Jensen et al., 2005; Santos et al., 2006;
Tzschach et al., 2006).
We did not observe global changes in H3K4 trimethyla-
tion when RBP2 was deleted from the mouse germline or
acutely inactivated in MEFs in vitro, presumably due to re-
dundancy with genes such as the other JARID1 family
members mentioned above. It is also likely that redun-
dancy is responsible for the viability of the RBP2/
mice. Nonetheless, individual JARID1 family members
are likely to have nonredundant roles in regulating certain
cellular functions, as we observed hematological abnor-
malities in the RBP2/ mice that correlated with dere-
pression of RBP2 target cytokine genes such as SDF1.
Further analysis of these mice should more clearly define896 Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc.the contribution of SDF1 in this setting and, more globally,
to the nonredundant roles for RBP2 demethylase activity
in vivo.
Interestingly, as a result of alternative splicing RBP2
contains either two or three PHD domains. The PHD do-
mains of two other chromatin associated proteins, BPTF
and ING2, have recently been shown to recognize trime-
thylated H3K4 (Li et al., 2006; Pena et al., 2006; Shi
et al., 2006; Wysocka et al., 2006), indicating that the
PHD domains may contribute to RBP2’s ability to serve
as a demethylase. It is intriguing that RBP2 has multiple
PHD domains, however, and that the number of PHD do-
mains is potentially regulated. Conceivably the multiple
PHD domains bind independently, in cis, to appropriately
modified H3 molecules and, as a result, ensure that RBP2
only recognizes adjacent methylated histones that have
the proper spacing and orientation. It is also possible
that this domain architecture contributes to the spacing
with which RBP2 subsequently removes trimethylatedFigure 6. Wild-Type RBP2, but Not JmjC
Domain Mutant RBP2, Demethylates
H3K4me3 at the SDF1 Promoter
(A) Immunoblot analysis of RBP2/ (KO)
MEFs that were stably infected with retrovi-
ruses expressing wild-type RBP2 (WT),
RBP2-H483A (MT), or empty virus (EV). Unin-
fected RBP2+/+ (WT) MEFs were included as
a control.
(B–D) Abundance of H3K4me3 (B), H3K4me2
(C), and H3K4me1 (D) on the p3 region of
SDF1, as determined by quantitative, real-
time PCR analysis following ChIP of RBP2/
cells infected as in (A). Data are normalized to
recovery using H3 antibody and are repre-
sented as mean ± SD.
H3K4 and/or contributes to its processivity. For example,
the interaction of one PHD domain with trimethylated
H3K4 might have to breathe in order for the previously
bound trimethylated H3K4 to be acted upon by the adja-
cent JmjC domain. Once demethylated, RBP2 might slide
along the chromatin until all of its PHD domains were again
occupied by trimethylated H3K4.
2-oxoglutarate-dependent hydroxylases can be in-
hibited with drug-like small organic molecules (Epstein
et al., 2001; Ivan et al., 2002; Lando et al., 2002). The grow-
ing list of histone demethylases that belong to this family
raises the possibility that therapeutically advantageous
changes in gene expression might, in time, be achieved
by targeting specific demethylases with such compounds.
In this regard, RBP2 conceivably contributes to the trans-
formed phenotype in cancer cells that lack functional pRB
and its paralog, PLU1, is overexpressed in breast cancer
(Lu et al., 1999). It will be of interest to see whether genetic
or pharmacological disruption of these family members af-
fects tumor growth.
EXPERIMENTAL PROCEDURES
Constructs and Recombinant Protein
pcDNA3/HA-Flag-RBP2 was generated by inserting a Flag tag into the
Cla I site of pcDNA3/HA-RBP2 (Benevolenskaya et al., 2005). pBABE-
puro/HA-Flag-RBP2 was generated by inserting Flag-RBP2 cDNA into
pBABE-puro/HA vector (Kondo et al., 2002). The H483A substitution
mutation was introduced into pcDNA3/HA-Flag-RBP2 or pBABE-
puro/HA-Flag-RBP2 by site-directed mutagenesis using the Quik-
Change mutagenesis kit (Stratagene). For production of baculovirus-
expressed protein, RBP2 was cloned into the Sal I and Xba I sites of
a modified FastbacHTa (Invitrogen) vector engineered to contain an
N-terminal Flag-tag. Generation of baculovirus that expresses Flag-
RBP2 and purification of the recombinant protein from infected SF9
cells were performed as described previously (Cao and Zhang,
2004). Additional details are provided in the Supplemental Data.
Antibodies
The RBP2 antibodies 1416 and 2471 were described previously (Be-
nevolenskaya et al., 2005). The anti-RBP2 polyclonal antibody 2470
was raised in rabbits against glutathione S-transferase (GST)-RBP2
(1311–1358). Flag monoclonal M2 antibody and a-tubulin antibody
(clone B-5-1-2) were from Sigma. H3K4me3 antibody (Ab8580),
H3K4me1 antibody (Ab8895), H4K20me3 antibody (Ab9053), and H3
antibody (Ab1791) were from Abcam. H3K4me2 antibody (07-030),
H3K9me2 antibody (05-768), and H4R3me2 antibody (07-213) were
from Upstate. In some experiments, H3K4me2 antibody described
previously (Feng et al., 2002) was used.
Histone Demethylase Assays
Histone demethylase assays analyzing formaldehyde release were
carried out using equal counts of labeled histone substrate and purified
Flag-RBP2 as described previously (Tsukada et al., 2006), with the ex-
ception that a SET7 Y245A mutant was used to generate H3K4 sub-
strate. Histone-demethylase assays using modified histone peptide
substrates were carried out as described (Klose et al., 2006b) using
peptides corresponding to amino acids 1–18 of histone H3 (Upstate
12-563[me1], Upstate 12-460[me2], and Upstate 12-564[me3]).
Immunofluorescence
Indirect immunoflourscence was carried out using NIH3T3 cells grown
in DMEM containing 10% fetal bovine serum (FBS) and penicillin/streptomycin. Cells grown on coverslips in 6-well plates were trans-
fected with 2 mg of HA-Flag-RBP2 or HA-Flag-RBP2-H483A expres-
sion plasmid using FuGene 6 transfection reagent (Roche). Cells
were fixed 24 hr posttransfection for 20 min in 4% paraformaldehyde,
washed three times with PBS, and subsequently permeabilized for 20
min in 0.5% TritonX-100/PBS. Permeablized cells were washed two
times in PBS and blocked in 3% BSA/PBS for 30 min. Cells were incu-
bated with primary antibody in a humidified chamber for 1–3 hr using
histone-modification antibodies at a dilution of 1:100–1:1000 and the
Flag monoclonal M2 antibody (Sigma) at a dilution of 1:1000. After pri-
mary antibody incubation, cells were washed three times and incu-
bated with FITC or Rhodamine conjugated secondary antibodies
(Jackson ImmunoResearch Laboratories). Cells were washed twice
with PBS, stained with 4,6-diamidino-2-phenylindole dihydrochloride
(DAPI), and mounted on glass slides in fluorescent mounting medium
(DAKO). Slides were analyzed on an AxioSkop fluorescent microscope
(Zeiss).
Construction of the Targeting Vector and Generation
of RBP2-Deficient Mice
We isolated the RBP2 locus from RPCI-22 bacterial artificial chromo-
some library (Osoegawa et al., 2000). A conditional RBP2 targeting
vector was generated by flanking RBP2 exons 5 and 6 with a 50 loxP
site and a 30 Frt-PGK-neomycin-Frt-LoxP expression cassette
(Bardeesy et al., 2002). After electroporation of 129/SvEv embryonic
stem (ES) cells and selection at 200 mg/ml G418, we screened 192
ES cell clones by PCR and Southern blot analysis and identified 11 cor-
rect recombinants at the RBP2 locus. Two of the correctly targeted ES
clones were injected into C57BL/6 blastocysts, and chimeric mice
were bred into C57BL/6. Germline transmitting mice were bred to
CAGG-Flpe (Rodriguez et al., 2000) and EIIa-Cre (Lakso et al., 1996)
transgenic mice to generate the lox and null alleles, respectively.
Cre+RBP2+/ and Flpe+RBP2+/lox mice were backcrossed once or
twice to C57BL/6, and progeny of these crosses that were Cre and
Flpe were then used to generate the experimental cohort. The geno-
types of the mice were determined by multiplex PCR, Southern blot
analysis, or by Quantitative PCR (Transnetyx). Primers used for multi-
plex PCR in genotyping analysis are available in the Supplemental
Data. All mice were maintained in the research animal facility of the
Dana-Farber Cancer Institute in accordance with the NIH guidelines,
and all procedures involving mice were approved by the Dana-Farber
Cancer Institute IACUC.
Cell Culture
MEFs were isolated from 13.5 days postcoitum (dpc) embryos using
standard procedures. MEFs were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% FBS (Hyclone). Phoenix
packaging cells (a generous gift of Dr. Gary Nolan, Department of
Molecular Pharmacology, Stanford University, CA) cells were grown
in DMEM containing 10% FBS. Retroviral plasmids were transfected
into the Phoenix cells using FuGene 6 reagent (Roche Molecular
Biochemicals) according to the manufacturer’s instructions. Tissue-
culture supernatant containing retroviruses was harvested 48 hr later,
passed though a 0.45 mm filter, and added to cells in the presence of
4 mg/ml polybrene. Immortalized MEFs were generated by stably in-
fecting the primary MEFs with retroviruses encoding the K1 mutant
of the SV40 large T antigen, which inactivates p53 pathway, but not
pRB pathway (Quartin et al., 1994). To acutely inactivate RBP2, immor-
talized RBP2+/lox or RBP2lox/lox MEFs were infected with retrovi-
ruses encoding Cre recombinase. To reintroduce RBP2 into the im-
mortalized RBP2/ MEFs, cells were stably infected with
retroviruses encoding wild-type RBP2 or RBP2-H483A mutant and
maintained in media containing 3 mg/ml puromycin.
Western Blot Analysis and ELISA
See the Supplemental Data.Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc. 897
Real-Time RT-PCR
Total RNA was isolated using RNeasy mini kit with on-column DNase
digestion (Qiagen). First-strand cDNA was generated using Strata-
Script First-Stand Synthesis System (Statagene). Real-time PCR was
performed in triplicate using QuantiTect SYBR Green PCR master
mix (Qiagen) and the Mx3000P QPCR system (Stratagene). Primers
are described in the Supplemental Data. All values were normalized
to the level of GAPDH mRNA abundance.
Cell Staining and FACS Analysis
For multiparameter flow cytometry, bone-marrow mononuclear cells
were flushed from hind-leg bones with RPMI (Cambrex, Biowhittaker)
containing 10% FBS (Gibco) and penicillin/streptomycin (Cambrex, Bi-
owhittaker), incubated on ice with red blood cell lysis solution (Pure-
gene) and washed in PBS (Gibco) containing 2% FBS. LSK, CMP,
GMP, MEP, and CLP populations were analyzed using a FACSAria in-
strument (Becton Dickinson, Mountain View, CA) as previously re-
ported (Akashi et al., 2000; Kondo et al., 1997). Apoptosis was deter-
mined by staining freshly harvested bone-marrow mononuclear cells
with lineage, stem, and progenitor markers, followed by Annexin-V
and 7-AAD staining. Cell-cycle analysis was carried out as previously
reported (Cheng et al., 2000). Additional analyses were carried out
on a 4-color FACSCalibur cytometer (Becton Dickinson, Mountain
View, CA) using samples that were washed with PBS and 0.1% bovine
serum albumin (BSA) (Sigma), blocked with Fc-block (BD-Pharmingen)
for 10 min, and stained with the following monoclonal antibodies in
PBS + 0.1% BSA for 30 min: B220-APC, Mac-1-FITC, Gr-1-APC,
and 7-AAD. A minimum of 10,000 events was acquired and analyzed
using CellQuest software.
Gene-Expression Profiling
Subconfluent wild-type and RBP2/ primary MEFs at passage 3
were harvested for RNA isolation using RNeasy mini kit with on-column
DNase digestion (Qiagen). Gene-expression profiling was performed
using the Affymetrix M430 2.0 chip. Analysis of the raw gene expres-
sion profiling was performed using dChip software (Li and Hung
Wong, 2001). mRNA expression levels in RBP2/ MEFs were com-
pared to wild-type MEFs. The genes listed were selected if they
were up- or downregulated 1.5-fold in each of the duplicate experi-
ments and up- or downregulated by 2-fold or more on average in
RBP2/ MEFs. The gene-expression profiling data can be found in
the Gene Expression Omnibus (GEO) of NCBI at http://www.ncbi.
nlm.nih.gov/geo/ through accession number GSE6945.
ChIP
Subconfluent RBP2+/+ and RBP2/ MEFs grown in 150 mm dishes
were first treated with DMEM containing 1% formaldehyde for 15 min.
The crosslinking was stopped by the addition of 0.125 M glycine for
5 min. After washing twice with PBS, the cells were resuspended in
1 ml of lysis buffer A (10 mM Tris HCl (pH 7.5), 10 mM KCl, 5 mM
MgCl2, 0.5% NP40) with 1 mM PMSF and incubated on ice for
10 min. After centrifugation at 2000 rpm for 5 min, the cell pellets
were resuspended in SDS lysis buffer (50 mM Tris HCl (pH 7.9),
10 mM EDTA, 0.5% SDS) supplemented with completer protease in-
hibitor cocktail (Roche Molecular Biochemicals). The chromatin sam-
ples were then sonicated into fragments with an average length of
1 kb. After centrifugation at 13,000 rpm for 10 min, the supernatants
were diluted 1:4 with ChIP dilution buffer (12.5 mM Tris HCl [pH 7.9],
187.5 mM NaCl, 1.25% Triton X-100) containing protease inhibitors.
ChIP assays were then performed with the indicated antibodies.
PCR analyses were then performed to determine the amount of targets
in the ChIP samples. In some cases, quantitative, real-time PCR was
performed in triplicate using QuantiTect SYBR Green PCR master
mix (Qiagen) and the Mx3000P QPCR system (Stratagene). Primers
are described in the Supplemental Data. The relative amount of immu-
noprecipitated DNA to input DNA or immunoprecipitated DNA by
histone H3 antibody was plotted in the figures.898 Cell 128, 889–900, March 9, 2007 ª2007 Elsevier Inc.Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, three figures, and two tables and can be
found with this article online at http://www.cell.com/cgi/content/full/
128/5/889/DC1/.
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